Prognostic value of tumor‑infiltrating lymphocytes in estrogen receptor‑positive and human epidermal growth factor receptor 2‑negative breast cancer-Reference-Cited by-同舟云学术

Prognostic value of tumor‑infiltrating lymphocytes in estrogen receptor‑positive and human epidermal growth factor receptor 2‑negative breast cancer

Published:2021-10-08 Issue:6 Volume:15 Page:
ISSN:2049-9450
Container-title:Molecular and Clinical Oncology
language:
Short-container-title:Mol Clin Oncol

Author:

Honda Chikako¹,Kurozumi Sasagu¹,Katayama Ayaka²,Hanna‑Khalil Bishoy³,Masuda Kei²,Nakazawa Yuko¹,Ogino Misato¹,Obayashi Sayaka¹,Yajima Reina¹,Makiguchi Takaya⁴,Oyama Tetsunari²,Horiguchi Jun⁵,Shirabe Ken¹,Fujii Takaaki¹

Affiliation:

1. Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Gunma 371‑8511, Japan

2. Department of Diagnostic Pathology, Gunma University Graduate School of Medicine, Maebashi, Gunma 371‑8511, Japan

3. School of Biological and Chemical Sciences, Queen Mary University of London, London E1 4NS, UK

4. Department of Oral and Maxillofacial Surgery, and Plastic Surgery, Gunma University Graduate School of Medicine, Maebashi, Gunma 371‑8511, Japan

5. Department of Breast Surgery, International University of Health and Welfare, Chiba 286‑8520, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utility of human epidermal growth factor 2 heterogeneity as a prognostic factor in triple-negative breast cancer;Medical Molecular Morphology;2024-04-15

2. Clinical Relevance of Tumour-Infiltrating Immune Cells in HER2-Negative Breast Cancer Treated with Neoadjuvant Therapy;International Journal of Molecular Sciences;2024-02-23

3. A key molecular driver of tumor-infiltrating lymphocytes in invasive breast cancer on machine learning–based meta-mining research;2023-10-11

4. Evaluation of tumour infiltrating lymphocytes in luminal breast cancer using artificial intelligence;British Journal of Cancer;2023-09-30

5. Tumor-infiltrating lymphocytes provides recent survival information for early-stage HER2-low-positive breast cancer: a large cohort retrospective study;Frontiers in Oncology;2023-06-20